STUB1 and hepatocellular carcinoma: In the future, the results of immune infiltration can be further validated by transcriptomics, immunohistochemistry and flow cytometry, and the more specific mechanism of marker lncRNA in HCC can be validated by qPCR, dual-luciferase report assay, RNA in situ Hybridization, RNA Affinity Purification, CHIP-Seq, knockdown or overexpression experiments.